Composition | Each tablet contains fluralaner as the active ingredient in the following amounts: 112.5 mg, 250 mg, 500 mg, 1000 mg, and 1400 mg. |
|---|
Indications for use | Used for the prevention and treatment of acariasis caused by ixodid ticks (Ixodes ricinus, Ixodes hexagonus, Ixodes scapularis, Ixodes holocyclus, Dermacentor reticulatus, Dermacentor variabilis, and Rhipicephalus sanguineus): — to reduce the risk of babesiosis transmitted by ixodid ticks infected with Babesia canis; — for the prevention and treatment of entomoses caused by fleas (Ctenocephalides felis and Ctenocephalides canis); — as part of complex therapy for flea allergy dermatitis; — for the prevention of dipylidiasis transmitted by fleas infected with larvae of the helminth Dipylidium caninum; — for the treatment of demodicosis caused by Demodex canis; — for the treatment of sarcoptic mange caused by Sarcoptes scabiei. |
|---|